Clemens Scherzer - Publications

Affiliations: 
Harvard Medical School, Boston, MA, United States 
Area:
Translational Genomics of Parkinson’s Disease: Cause, Cures, Diagnostics

45/101 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Huh YE, Ruby Chiang MS, Locascio JJ, Liao Z, Liu G, Choudhury K, Kuras YI, Tuncali I, Videnovic A, Hunt AL, Schwarzschild MA, Hung AY, Herrington TM, Hayes MT, Hyman BT, ... ... Scherzer CR, et al. β-Glucocerebrosidase Activity in -linked Parkinson's Disease: The Type of Mutation Matters. Neurology. PMID 32540937 DOI: 10.1212/Wnl.0000000000009989  0.32
2020 Bakshi R, Macklin EA, Hung AY, Hayes MT, Hyman BT, Wills AM, Gomperts SN, Growdon JH, Ascherio A, Scherzer CR, Schwarzschild MA. Associations of Lower Caffeine Intake and Plasma Urate Levels with Idiopathic Parkinson's Disease in the Harvard Biomarkers Study. Journal of Parkinson's Disease. 10: 505-510. PMID 32250320 DOI: 10.3233/Jpd-191882  0.32
2017 Mittal S, Bjørnevik K, Im DS, Flierl A, Dong X, Locascio JJ, Abo KM, Long E, Jin M, Xu B, Xiang YK, Rochet JC, Engeland A, Rizzu P, Heutink P, ... ... Scherzer CR, et al. β2-Adrenoreceptor is a regulator of the α-synuclein gene driving risk of Parkinson's disease. Science (New York, N.Y.). 357: 891-898. PMID 28860381 DOI: 10.1126/Science.Aaf3934  0.32
2016 Chhatwal JP, Schultz AP, Marshall GA, Boot B, Gomez-Isla T, Dumurgier J, LaPoint M, Scherzer C, Roe AD, Hyman BT, Sperling RA, Johnson KA. Temporal T807 binding correlates with CSF tau and phospho-tau in normal elderly. Neurology. PMID 27473132 DOI: 10.1212/Wnl.0000000000003050  0.4
2016 Takeda S, Commins C, DeVos SL, Nobuhara CK, Wegmann S, Roe AD, Costantino I, Fan Z, Nicholls SB, Sherman AE, Trisini Lipsanopoulos AT, Scherzer CR, Carlson GA, Pitstick R, Peskind ER, et al. Seed-competent HMW tau species accumulates in the cerebrospinal fluid of Alzheimer's disease mouse model and human patients. Annals of Neurology. PMID 27351289 DOI: 10.1002/Ana.24716  0.4
2016 Lööv C, Scherzer CR, Hyman BT, Breakefield XO, Ingelsson M. α-Synuclein in Extracellular Vesicles: Functional Implications and Diagnostic Opportunities. Cellular and Molecular Neurobiology. PMID 26993503 DOI: 10.1007/S10571-015-0317-0  0.4
2016 Bakshi R, Mittal S, Liao Z, Scherzer CR. A feed-forward circuit of endogenous PGC-1α and estrogen related receptor α regulates the neuronal electron transport chain Parkinson's Disease. 2016. DOI: 10.1155/2016/2405176  0.4
2015 Rosenthal LS, Drake D, Alcalay RN, Babcock D, Bowman FD, Chen-Plotkin A, Dawson TM, Dewey RB, German DC, Huang X, Landin B, McAuliffe M, Petyuk VA, Scherzer CR, Hillaire-Clarke CS, et al. The NINDS Parkinson's disease biomarkers program. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 26442452 DOI: 10.1002/Mds.26438  0.4
2015 Sorond FA, Cruz-Almeida Y, Clark DJ, Viswanathan A, Scherzer CR, De Jager P, Csiszar A, Laurienti PJ, Hausdorff J, Chen WG, Ferrucci L, Rosano C, Studenski SA, Black SE, Lipsitz LA. Aging, the Central Nervous System, and Mobility in Older Adults: Neural Mechanisms of Mobility Impairment. The Journals of Gerontology. Series a, Biological Sciences and Medical Sciences. PMID 26386013 DOI: 10.1093/Gerona/Glv130  0.4
2015 Locascio JJ, Eberly S, Liao Z, Liu G, Hoesing AN, Duong K, Trisini-Lipsanopoulos A, Dhima K, Hung AY, Flaherty AW, Schwarzschild MA, Hayes MT, Wills AM, Shivraj Sohur U, Mejia NI, ... ... Scherzer CR, et al. Association between α-synuclein blood transcripts and early, neuroimaging-supported Parkinson's disease. Brain : a Journal of Neurology. 138: 2659-71. PMID 26220939 DOI: 10.1093/Brain/Awv202  0.32
2015 Locascio JJ, Eberly S, Liao Z, Liu G, Hoesing AN, Duong K, Trisini-Lipsanopoulos A, Dhima K, Hung AY, Flaherty AW, Schwarzschild MA, Hayes MT, Wills AM, Shivraj Sohur U, Mejia NI, ... ... Scherzer CR, et al. Association between α-synuclein blood transcripts and early, neuroimaging-supported Parkinson's disease Brain. 138: 2659-2671. DOI: 10.1093/brain/awv202  0.4
2014 Santiago JA, Scherzer CR, Potashkin JA. Network analysis identifies SOD2 mRNA as a potential biomarker for Parkinson's disease. Plos One. 9: e109042. PMID 25279756 DOI: 10.1371/journal.pone.0109042  0.4
2014 Ziegler DA, Ashourian P, Wonderlick JS, Sarokhan AK, Prelec D, Scherzer CR, Corkin S. Motor impulsivity in Parkinson disease: associations with COMT and DRD2 polymorphisms. Scandinavian Journal of Psychology. 55: 278-86. PMID 24749760 DOI: 10.1111/sjop.12113  0.4
2014 Cebrián C, Zucca FA, Mauri P, Steinbeck JA, Studer L, Scherzer CR, Kanter E, Budhu S, Mandelbaum J, Vonsattel JP, Zecca L, Loike JD, Sulzer D. MHC-I expression renders catecholaminergic neurons susceptible to T-cell-mediated degeneration. Nature Communications. 5: 3633. PMID 24736453 DOI: 10.1038/Ncomms4633  0.4
2014 Cesani M, Cavalca E, Macco R, Leoncini G, Terreni MR, Lorioli L, Furlan R, Comi G, Doglioni C, Zacchetti D, Sessa M, Scherzer CR, Biffi A. Metallothioneins as dynamic markers for brain disease in lysosomal disorders. Annals of Neurology. 75: 127-37. PMID 24242821 DOI: 10.1002/ana.24053  0.4
2013 Santiago JA, Scherzer CR, Potashkin JA, Hyman BT, Ivinson AJ, Trisini-Lipsanopoulos A, Dhima K, Bayer S, Lockhart KC, Yi T, Liao Z, Hoesing AN, Duong K, Roderick S, Sudarsky LR, et al. Specific splice variants are associated with Parkinson's disease Movement Disorders. 28: 1724-1727. PMID 24108702 DOI: 10.1002/mds.25635  0.4
2013 Ding H, Dhima K, Lockhart KC, Locascio JJ, Hoesing AN, Duong K, Trisini-Lipsanopoulos A, Hayes MT, Sohur US, Wills AM, Mollenhauer B, Flaherty AW, Hung AY, Mejia N, Khurana V, ... ... Scherzer CR, et al. Unrecognized vitamin D3 deficiency is common in Parkinson disease: Harvard Biomarker Study. Neurology. 81: 1531-7. PMID 24068787 DOI: 10.1212/Wnl.0B013E3182A95818  0.4
2013 Thomas B, Matson S, Chopra V, Sun L, Sharma S, Hersch S, Rosas HD, Scherzer C, Ferrante R, Matson W. A novel method for detecting 7-methyl guanine reveals aberrant methylation levels in Huntington disease. Analytical Biochemistry. 436: 112-20. PMID 23416183 DOI: 10.1016/J.Ab.2013.01.035  0.4
2012 Pankratz N, Beecham GW, DeStefano AL, Dawson TM, Doheny KF, Factor SA, Hamza TH, Hung AY, Hyman BT, Ivinson AJ, Krainc D, Latourelle JC, Clark LN, Marder K, Martin ER, ... ... Scherzer CR, et al. Meta-analysis of Parkinson's disease: identification of a novel locus, RIT2. Annals of Neurology. 71: 370-84. PMID 22451204 DOI: 10.1002/Ana.22687  0.4
2011 van Blitterswijk M, Gulati S, Smoot E, Jaffa M, Maher N, Hyman BT, Ivinson AJ, Scherzer CR, Schoenfeld DA, Cudkowicz ME, Brown RH, Bosco DA. Anti-superoxide dismutase antibodies are associated with survival in patients with sporadic amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group On Motor Neuron Diseases. 12: 430-8. PMID 22023190 DOI: 10.3109/17482968.2011.585163  0.4
2011 Hu Y, Chopra V, Chopra R, Locascio JJ, Liao Z, Ding H, Zheng B, Matson WR, Ferrante RJ, Rosas HD, Hersch SM, Scherzer CR. Transcriptional modulator H2A histone family, member Y (H2AFY) marks Huntington disease activity in man and mouse. Proceedings of the National Academy of Sciences of the United States of America. 108: 17141-6. PMID 21969577 DOI: 10.1073/Pnas.1104409108  0.4
2011 Ding H, Sarokhan AK, Roderick SS, Bakshi R, Maher NE, Ashourian P, Kan CG, Chang S, Santarlasci A, Swords KE, Ravina BM, Hayes MT, Sohur US, Wills AM, Flaherty AW, ... ... Scherzer CR, et al. Association of SNCA with Parkinson: replication in the Harvard NeuroDiscovery Center Biomarker Study. Movement Disorders : Official Journal of the Movement Disorder Society. 26: 2283-6. PMID 21953863 DOI: 10.1002/Mds.23934  0.4
2011 Hakimi M, Selvanantham T, Swinton E, Padmore RF, Tong Y, Kabbach G, Venderova K, Girardin SE, Bulman DE, Scherzer CR, LaVoie MJ, Gris D, Park DS, Angel JB, Shen J, et al. Parkinson's disease-linked LRRK2 is expressed in circulating and tissue immune cells and upregulated following recognition of microbial structures. Journal of Neural Transmission (Vienna, Austria : 1996). 118: 795-808. PMID 21552986 DOI: 10.1007/S00702-011-0653-2  0.4
2010 Zheng B, Liao Z, Locascio JJ, Lesniak KA, Roderick SS, Watt ML, Eklund AC, Zhang-James Y, Kim PD, Hauser MA, Grünblatt E, Moran LB, Mandel SA, Riederer P, Miller RM, ... ... Scherzer CR, et al. PGC-1α, a potential therapeutic target for early intervention in Parkinson's disease. Science Translational Medicine. 2: 52ra73. PMID 20926834 DOI: 10.1126/Scitranslmed.3001059  0.4
2010 Khurana V, Elson-Schwab I, Fulga TA, Sharp KA, Loewen CA, Mulkearns E, Tyynelä J, Scherzer CR, Feany MB. Lysosomal dysfunction promotes cleavage and neurotoxicity of tau in vivo. Plos Genetics. 6: e1001026. PMID 20664788 DOI: 10.1371/Journal.Pgen.1001026  0.4
2010 Lipinski MM, Zheng B, Lu T, Yan Z, Py BF, Ng A, Xavier RJ, Li C, Yankner BA, Scherzer CR, Yuan J. Genome-wide analysis reveals mechanisms modulating autophagy in normal brain aging and in Alzheimer's disease. Proceedings of the National Academy of Sciences of the United States of America. 107: 14164-9. PMID 20660724 DOI: 10.1073/Pnas.1009485107  0.4
2010 Cho HH, Cahill CM, Vanderburg CR, Scherzer CR, Wang B, Huang X, Rogers JT. Selective translational control of the Alzheimer amyloid precursor protein transcript by iron regulatory protein-1. The Journal of Biological Chemistry. 285: 31217-32. PMID 20558735 DOI: 10.1074/Jbc.M110.149161  0.4
2010 Kim J, Amante DJ, Moody JP, Edgerly CK, Bordiuk OL, Smith K, Matson SA, Matson WR, Scherzer CR, Rosas HD, Hersch SM, Ferrante RJ. Reduced creatine kinase as a central and peripheral biomarker in Huntington's disease. Biochimica Et Biophysica Acta. 1802: 673-81. PMID 20460152 DOI: 10.1016/J.Bbadis.2010.05.001  0.4
2009 Scherzer C. Interview with Clemens Scherzer--searching for biomarkers in Parkinson's disease. Biomarkers in Medicine. 3: 113-4. PMID 20477503 DOI: 10.2217/Bmm.09.10  0.4
2009 Scherzer CR. Chipping away at diagnostics for neurodegenerative diseases. Neurobiology of Disease. 35: 148-56. PMID 19285134 DOI: 10.1016/j.nbd.2009.02.016  0.4
2008 Hennecke G, Scherzer CR. RNA biomarkers of Parkinson's disease: developing tools for novel therapies. Biomarkers in Medicine. 2: 41-53. PMID 20477362 DOI: 10.2217/17520363.2.1.41  0.4
2008 Scherzer CR, Grass JA, Liao Z, Pepivani I, Zheng B, Eklund AC, Ney PA, Ng J, McGoldrick M, Mollenhauer B, Bresnick EH, Schlossmacher MG. GATA transcription factors directly regulate the Parkinson's disease-linked gene alpha-synuclein. Proceedings of the National Academy of Sciences of the United States of America. 105: 10907-12. PMID 18669654 DOI: 10.1073/Pnas.0802437105  0.4
2007 Scherzer CR, Eklund AC, Morse LJ, Liao Z, Locascio JJ, Fefer D, Schwarzschild MA, Schlossmacher MG, Hauser MA, Vance JM, Sudarsky LR, Standaert DG, Growdon JH, Jensen RV, Gullans SR. Molecular markers of early Parkinson's disease based on gene expression in blood. Proceedings of the National Academy of Sciences of the United States of America. 104: 955-60. PMID 17215369 DOI: 10.1073/pnas.0610204104  0.4
2006 Xu PT, Li YJ, Qin XJ, Scherzer CR, Xu H, Schmechel DE, Hulette CM, Ervin J, Gullans SR, Haines J, Pericak-Vance MA, Gilbert JR. Differences in apolipoprotein E3/3 and E4/4 allele-specific gene expression in hippocampus in Alzheimer disease. Neurobiology of Disease. 21: 256-75. PMID 16198584 DOI: 10.1016/J.Nbd.2005.07.004  0.4
2005 Hauser MA, Li YJ, Xu H, Noureddine MA, Shao YS, Gullans SR, Scherzer CR, Jensen RV, McLaurin AC, Gibson JR, Scott BL, Jewett RM, Stenger JE, Schmechel DE, Hulette CM, et al. Expression profiling of substantia nigra in Parkinson disease, progressive supranuclear palsy, and frontotemporal dementia with parkinsonism. Archives of Neurology. 62: 917-21. PMID 15956162 DOI: 10.1001/Archneur.62.6.917  0.4
2004 Scherzer CR, Offe K, Gearing M, Rees HD, Fang G, Heilman CJ, Schaller C, Bujo H, Levey AI, Lah JJ. Loss of apolipoprotein E receptor LR11 in Alzheimer disease. Archives of Neurology. 61: 1200-5. PMID 15313836 DOI: 10.1001/Archneur.61.8.1200  0.4
2004 Scherzer CR, Feany MB. Yeast genetics targets lipids in Parkinson's disease. Trends in Genetics : Tig. 20: 273-7. PMID 15219388 DOI: 10.1016/J.Tig.2004.05.005  0.4
2003 Li YJ, Oliveira SA, Xu P, Martin ER, Stenger JE, Scherzer CR, Hauser MA, Scott WK, Small GW, Nance MA, Watts RL, Hubble JP, Koller WC, Pahwa R, Stern MB, et al. Glutathione S-transferase omega-1 modifies age-at-onset of Alzheimer disease and Parkinson disease. Human Molecular Genetics. 12: 3259-67. PMID 14570706 DOI: 10.1093/Hmg/Ddg357  0.4
2003 Scherzer CR, Jensen RV, Gullans SR, Feany MB. Gene expression changes presage neurodegeneration in a Drosophila model of Parkinson's disease. Human Molecular Genetics. 12: 2457-66. PMID 12915459 DOI: 10.1093/Hmg/Ddg265  0.4
2001 Thambisetty MR, Scherzer CR, Yu Z, Lennon VA, Newman NJ. Paraneoplastic optic neuropathy and cerebellar ataxia with small cell carcinoma of the lung. Journal of Neuro-Ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society. 21: 164-7. PMID 11725180  0.4
1998 Counihan TJ, Landwehrmeyer GB, Standaert DG, Kosinski CM, Scherzer CR, Daggett LP, Veliçelebi G, Young AB, Penney JB. Expression of N-methyl-D-aspartate receptor subunit mRNA in the human brain: mesencephalic dopaminergic neurons. The Journal of Comparative Neurology. 390: 91-101. PMID 9456178 DOI: 10.1002/(SICI)1096-9861(19980105)390:1<91::AID-CNE8>3.0.CO;2-L  0.4
1998 Scherzer CR, Landwehrmeyer GB, Kerner JA, Counihan TJ, Kosinski CM, Standaert DG, Daggett LP, Veliçelebi G, Penney JB, Young AB. Expression of N-methyl-D-aspartate receptor subunit mRNAs in the human brain: hippocampus and cortex. The Journal of Comparative Neurology. 390: 75-90. PMID 9456177 DOI: 10.1002/(SICI)1096-9861(19980105)390:1<75::AID-CNE7>3.0.CO;2-N  0.4
1998 Kosinski CM, Standaert DG, Counihan TJ, Scherzer CR, Kerner JA, Daggett LP, Veliçelebi G, Penney JB, Young AB, Landwehrmeyer GB. Expression of N-methyl-D-aspartate receptor subunit mRNAs in the human brain: striatum and globus pallidus. The Journal of Comparative Neurology. 390: 63-74. PMID 9456176 DOI: 10.1002/(SICI)1096-9861(19980105)390:1<63::AID-CNE6>3.0.CO;2-O  0.4
1997 Priller J, Scherzer CR, Faber PW, MacDonald ME, Young AB. Frataxin gene of Friedreich's ataxia is targeted to mitochondria. Annals of Neurology. 42: 265-9. PMID 9266741 DOI: 10.1002/ana.410420222  0.4
1997 Scherzer CR, Landwehrmeyer GB, Kerner JA, Standaert DG, Hollingsworth ZR, Daggett LP, Veliçelebi G, Penney JB, Young AB. Cellular distribution of NMDA glutamate receptor subunit mRNAs in the human cerebellum. Neurobiology of Disease. 4: 35-46. PMID 9258910 DOI: 10.1006/nbdi.1997.0136  0.4
Low-probability matches
2021 Tokarew JM, El-Kodsi DN, Lengacher NA, Fehr TK, Nguyen AP, Shutinoski B, O'Nuallain B, Jin M, Khan JM, Ng ACH, Li J, Jiang Q, Zhang M, Wang L, Sengupta R, ... ... Scherzer CR, et al. Age-associated insolubility of parkin in human midbrain is linked to redox balance and sequestration of reactive dopamine metabolites. Acta Neuropathologica. PMID 33694021 DOI: 10.1007/s00401-021-02285-4  0.28
2020 Iwaki H, Blauwendraat C, Leonard HL, Makarious MB, Kim JJ, Liu G, Maple-Grødem J, Corvol JC, Pihlstrøm L, van Nimwegen M, Smolensky L, Amondikar N, Hutten SJ, Frasier M, Nguyen KH, ... ... Scherzer CR, et al. Differences in the Presentation and Progression of Parkinson's Disease by Sex. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 33002231 DOI: 10.1002/mds.28312  0.24
2019 Iwaki H, Blauwendraat C, Leonard HL, Kim JJ, Liu G, Maple-Grødem J, Corvol JC, Pihlstrøm L, van Nimwegen M, Hutten SJ, Nguyen KH, Rick J, Eberly S, Faghri F, Auinger P, ... ... Scherzer CR, et al. Genomewide association study of Parkinson's disease clinical biomarkers in 12 longitudinal patients' cohorts. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 31505070 DOI: 10.1002/Mds.27845  0.24
2019 Iwaki H, Blauwendraat C, Leonard HL, Liu G, Maple-Grødem J, Corvol JC, Pihlstrøm L, van Nimwegen M, Hutten SJ, Nguyen KH, Rick J, Eberly S, Faghri F, Auinger P, Scott KM, ... ... Scherzer CR, et al. Genetic risk of Parkinson disease and progression:: An analysis of 13 longitudinal cohorts. Neurology. Genetics. 5: e348. PMID 31404238 DOI: 10.1212/Nxg.0000000000000348  0.24
2018 Dong X, Liao Z, Gritsch D, Hadzhiev Y, Bai Y, Locascio JJ, Guennewig B, Liu G, Blauwendraat C, Wang T, Adler CH, Hedreen JC, Faull RLM, Frosch MP, Nelson PT, ... ... Scherzer CR, et al. Publisher Correction: Enhancers active in dopamine neurons are a primary link between genetic variation and neuropsychiatric disease. Nature Neuroscience. PMID 30482917 DOI: 10.1038/S41593-018-0277-Z  0.24
2018 Dong X, Liao Z, Gritsch D, Hadzhiev Y, Bai Y, Locascio JJ, Guennewig B, Liu G, Blauwendraat C, Wang T, Adler CH, Hedreen JC, Faull RLM, Frosch MP, Nelson PT, ... ... Scherzer CR, et al. Enhancers active in dopamine neurons are a primary link between genetic variation and neuropsychiatric disease. Nature Neuroscience. PMID 30224808 DOI: 10.1038/S41593-018-0223-0  0.24
2017 Liu G, Locascio JJ, Corvol JC, Boot B, Liao Z, Page K, Franco D, Burke K, Jansen IE, Trisini-Lipsanopoulos A, Winder-Rhodes S, Tanner CM, Lang AE, Eberly S, Elbaz A, ... ... Scherzer CR, et al. Prediction of cognition in Parkinson's disease with a clinical-genetic score: a longitudinal analysis of nine cohorts. The Lancet. Neurology. PMID 28629879 DOI: 10.1016/S1474-4422(17)30122-9  0.24
2016 Liu G, Boot B, Locascio JJ, Jansen IE, Winder-Rhodes S, Eberly S, Elbaz A, Brice A, Ravina B, van Hilten JJ, Cormier-Dequaire F, Corvol JC, Barker RA, Heutink P, Marinus J, ... ... Scherzer CR, et al. Neuropathic Gaucher's mutations accelerate cognitive decline in Parkinson's. Annals of Neurology. PMID 27717005 DOI: 10.1002/ana.24781  0.24
2014 Doss S, Wandinger KP, Hyman BT, Panzer JA, Synofzik M, Dickerson B, Mollenhauer B, Scherzer CR, Ivinson AJ, Finke C, Schöls L, Müller Vom Hagen J, Trenkwalder C, Jahn H, Höltje M, et al. High prevalence of NMDA receptor IgA/IgM antibodies in different dementia types. Annals of Clinical and Translational Neurology. 1: 822-32. PMID 25493273 DOI: 10.1002/Acn3.120  0.16
2021 Lerche S, Schulte C, Wurster I, Machetanz G, Roeben B, Zimmermann M, Deuschle C, Hauser AK, Böhringer J, Krägeloh-Mann I, Waniek K, Lachmann I, Petterson XT, Chiang R, Park H, ... ... Scherzer CR, et al. The Mutation Matters: CSF Profiles of GCase, Sphingolipids, α-Synuclein in PD. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 33547828 DOI: 10.1002/mds.28472  0.12
2020 Rotunno MS, Lane M, Zhang W, Wolf P, Oliva P, Viel C, Wills AM, Alcalay RN, Scherzer CR, Shihabuddin LS, Zhang K, Sardi SP. Cerebrospinal fluid proteomics implicates the granin family in Parkinson's disease. Scientific Reports. 10: 2479. PMID 32051502 DOI: 10.1038/s41598-020-59414-4  0.12
2018 Chen-Plotkin AS, Albin R, Alcalay R, Babcock D, Bajaj V, Bowman D, Buko A, Cedarbaum J, Chelsky D, Cookson MR, Dawson TM, Dewey R, Foroud T, Frasier M, German D, ... ... Scherzer CR, et al. Finding useful biomarkers for Parkinson's disease. Science Translational Medicine. 10. PMID 30111645 DOI: 10.1126/Scitranslmed.Aam6003  0.12
2017 Gwinn K, David KK, Swanson-Fischer C, Albin R, Hillaire-Clarke CS, Sieber BA, Lungu C, Bowman FD, Alcalay RN, Babcock D, Dawson TM, Dewey RB, Foroud T, German D, Huang X, ... ... Scherzer CR, et al. Parkinson's disease biomarkers: perspective from the NINDS Parkinson's Disease Biomarkers Program. Biomarkers in Medicine. PMID 28644039 DOI: 10.2217/Bmm-2016-0370  0.12
2021 Chia R, Sabir MS, Bandres-Ciga S, Saez-Atienzar S, Reynolds RH, Gustavsson E, Walton RL, Ahmed S, Viollet C, Ding J, Makarious MB, Diez-Fairen M, Portley MK, Shah Z, Abramzon Y, ... ... Scherzer CR, et al. Genome sequencing analysis identifies new loci associated with Lewy body dementia and provides insights into its genetic architecture. Nature Genetics. PMID 33589841 DOI: 10.1038/s41588-021-00785-3  0.08
2020 Stoker TB, Camacho M, Winder-Rhodes S, Liu G, Scherzer CR, Foltynie T, Evans J, Breen DP, Barker RA, Williams-Gray CH. Impact of variants on long-term clinical progression and mortality in incident Parkinson's disease. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 32303560 DOI: 10.1136/jnnp-2020-322857  0.08
2016 Hill-Burns EM, Ross OA, Wissemann WT, Soto-Ortolaza AI, Zareparsi S, Siuda J, Lynch T, Wszolek ZK, Silburn PA, Mellick GD, Ritz B, Scherzer CR, Zabetian CP, Factor SA, Breheny PJ, et al. Identification of genetic modifiers of age-at-onset for familial Parkinson's disease. Human Molecular Genetics. PMID 27402877 DOI: 10.1093/Hmg/Ddw206  0.08
2021 Nasamran CA, Sachan ANS, Mott J, Kuras YI, Scherzer CR, Study HB, Ricciardelli E, Jepsen K, Edland SD, Fisch KM, Desplats P. Differential blood DNA methylation across Lewy body dementias. Alzheimer's & Dementia (Amsterdam, Netherlands). 13: e12156. PMID 33665346 DOI: 10.1002/dad2.12156  0.04
2017 Manocha GD, Floden AM, Puig KL, Nagamoto-Combs K, Scherzer CR, Combs CK. Defining the contribution of neuroinflammation to Parkinson's disease in humanized immune system mice. Molecular Neurodegeneration. 12: 17. PMID 28196514 DOI: 10.1186/s13024-017-0158-z  0.04
2014 Mehanna R, Scherzer CR, Ding H, Locascio JJ. Unrecognized vitamin D3 deficiency is common in Parkinson disease: Harvard Biomarker study. Neurology. 82: 1666; discussion 166. PMID 24799519 DOI: 10.1212/01.wnl.0000449750.81263.7d  0.04
2021 Anderson FL, von Herrmann KM, Andrew AS, Kuras YI, Young AL, Scherzer CR, Hickey WF, Lee SL, Havrda MC. Plasma-borne indicators of inflammasome activity in Parkinson's disease patients. Npj Parkinson's Disease. 7: 2. PMID 33398042 DOI: 10.1038/s41531-020-00147-6  0.01
2020 Lohr KM, Frost B, Scherzer C, Feany MB. Biotin rescues mitochondrial dysfunction and neurotoxicity in a tauopathy model. Proceedings of the National Academy of Sciences of the United States of America. PMID 33318181 DOI: 10.1073/pnas.1922392117  0.01
2020 Watzlawik JO, Hou X, Truban D, Ramnarine C, Barodia SK, Gendron TF, Heckman MG, DeTure M, Siuda J, Wszolek ZK, Scherzer CR, Ross OA, Bu G, Dickson DW, Goldberg MS, et al. Sensitive ELISA-based detection method for the mitophagy marker p-S65-Ub in human cells, autopsy brain, and blood samples. Autophagy. 1-16. PMID 33112198 DOI: 10.1080/15548627.2020.1834712  0.01
2020 Alcalay RN, Wolf P, Chiang MSR, Helesicova K, Zhang XK, Merchant K, Hutten SJ, Scherzer C, Caspell-Garcia C, Blauwendraat C, Foroud T, Nudelman K, Gan-Or Z, Simuni T, Chahine LM, et al. Longitudinal Measurements of Glucocerebrosidase activity in Parkinson's patients. Annals of Clinical and Translational Neurology. PMID 32888397 DOI: 10.1002/Acn3.51164  0.01
2020 Scherzer CR, Riise T, Locascio JJ. Reader response: Use of β2-adrenoreceptor agonist and antagonist drugs and risk of Parkinson disease. Neurology. 94: 898-899. PMID 32423986 DOI: 10.1212/WNL.0000000000009449  0.01
2020 Stoker TB, Camacho M, Winder-Rhodes S, Liu G, Scherzer CR, Foltynie T, Barker RA, Williams-Gray CH. A common polymorphism in is associated with accelerated motor decline in -Parkinson's disease. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 32241921 DOI: 10.1136/jnnp-2019-322210  0.01
2019 O'Bryant SE, Edwards M, Zhang F, Johnson LA, Hall J, Kuras Y, Scherzer CR. Potential two-step proteomic signature for Parkinson's disease: Pilot analysis in the Harvard Biomarkers Study. Alzheimer's & Dementia (Amsterdam, Netherlands). 11: 374-382. PMID 31080873 DOI: 10.1016/J.Dadm.2019.03.001  0.01
2019 Henderson-Smith A, Fisch KM, Hua J, Liu G, Ricciardelli E, Jepsen K, Huentelman M, Stalberg G, Edland SD, Scherzer CR, Dunckley T, Desplats P. DNA methylation changes associated with Parkinson's disease progression: outcomes from the first longitudinal genome-wide methylation analysis in blood. Epigenetics. 1-18. PMID 30871403 DOI: 10.1080/15592294.2019.1588682  0.01
2018 Olsen AL, Riise T, Scherzer CR. Discovering New Benefits From Old Drugs With Big Data-Promise for Parkinson Disease. Jama Neurology. PMID 29710184 DOI: 10.1001/jamaneurol.2018.0345  0.01
2016 Bakshi R, Mittal S, Liao Z, Scherzer CR. A Feed-Forward Circuit of Endogenous PGC-1α and Estrogen Related Receptor α Regulates the Neuronal Electron Transport Chain. Parkinson's Disease. 2016: 2405176. PMID 27088034 DOI: 10.1155/2016/2405176  0.01
2016 Schwarzschild M, Fitzgerald K, Bakshi R, Macklin E, Scherzer C, Ascherio A. Association of α-synuclein gene expression with Parkinson’s disease is attenuated with higher serum urate in the PPMI cohort Parkinsonism & Related Disorders. 22: e115. DOI: 10.1016/J.Parkreldis.2015.10.265  0.01
2014 Cesani M, Cavalca E, Macco R, Leoncini G, Terreni MR, Lorioli L, Comi G, Doglioni C, Zacchetti D, Sessa M, Scherzer CR, Biffi A. Metallothionein transcripts are dynamic markers for brain disease in lysosomal disorders Molecular Genetics and Metabolism. 111: S30. DOI: 10.1016/j.ymgme.2013.12.052  0.01
2014 Ward MA, Hyman B, Scherzer C, Trisini-Lipsanopoulos A, Ivinson AJ, Lößner C, Farztdinov V, Lovestone S, Pike I. P3-126: EXPLORATION OF PLASMA BIOMARKERS FOR ALZHEIMER'S DISEASE USING ISOTOPIC TANDEM MASS TAGS AND A COMBINED DIRECTED/DATA-DEPENDENT ACQUISITION NLC-MS/MS METHOD Alzheimer's & Dementia. 10: P674-P674. DOI: 10.1016/J.Jalz.2014.05.1215  0.01
2012 Starr TL, Rafi K, Stucker B, Scherzer CM. Controlling phase composition in selective laser melted stainless steels 23rd Annual International Solid Freeform Fabrication Symposium - An Additive Manufacturing Conference, Sff 2012. 439-446.  0.01
2010 Meador MAB, Scherzer CM, Vivod SL, Quade D, Nguyen BN. Epoxy reinforced aerogels made using a streamlined process Acs Applied Materials and Interfaces. 2: 2162-2168. DOI: 10.1021/am100422x  0.01
2009 Scherzer C, Windhagen H, Nellesen J, Crostack HA, Crostak HA, Rohn K, Witte F, Thorey F, Fehr M, Hauschild G. Comparative structural analysis of the canine femoral head in Legg-Calvé-Perthes disease. Veterinary Radiology & Ultrasound : the Official Journal of the American College of Veterinary Radiology and the International Veterinary Radiology Association. 50: 404-11. PMID 19697606 DOI: 10.1111/j.1740-8261.2009.01557.x  0.01
2009 Mollenhauer B, Trenkwalder C, Ng J, Locascio J, El-Agnaf O, Growdon J, Sudarsky L, Scherzer C, Schlossmacher M. Quantifizierung von α-Synuklein im Blut als Biomarker für M. Parkinson Aktuelle Neurologie. 36. DOI: 10.1055/s-0029-1238374  0.01
2009 Liao Z, Bakshi R, Bresnick E, Schlossmacher M, Zheng B, Scherzer C. P3.042 A GATA-2-switch model of a-synuclein overexpression in sporadic Parkinson's disease Parkinsonism & Related Disorders. 15: S159. DOI: 10.1016/S1353-8020(09)70606-6  0.01
2009 Kay D, Montimurro J, Schlossmacher M, Bresnick E, Stevens C, Zabetian C, Factor S, Higgins D, Scherzer C, Payami H. P3.039 Polymorphisms in the transcription factor gene GATA2 and GATA-2 target region in a-synuclein (SNCA) are associated with Parkinson's disease (PD) Parkinsonism & Related Disorders. 15: S158. DOI: 10.1016/S1353-8020(09)70603-0  0.01
2008 Scherzer C, Kager L, Gadner H, Zoubek A. Acute unilateral mydriasis. Caused by angel's trumpet | Akute unilaterale mydriasis. Verursacht durch kontakt mit engelstrompete Monatsschrift Fur Kinderheilkunde. 156: 899-901. DOI: 10.1007/s00112-008-1723-x  0.01
2008 Scherzer CB, Williams JM. Bringing sport psychology into the Athletic training room Athletic Therapy Today. 13: 15-17.  0.01
2007 Felder-Puig R, Scherzer C, Baumgartner M, Ortner M, Aschenbrenner C, Bieglmayer C, Voigtländer T, Panzer-Grümayer ER, Tissing WJ, Koper JW, Steinberger K, Nasel C, Gadner H, Topf R, Dworzak M. Glucocorticoids in the treatment of children with acute lymphoblastic leukemia and hodgkin's disease: a pilot study on the adverse psychological reactions and possible associations with neurobiological, endocrine, and genetic markers. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 13: 7093-100. PMID 18056188 DOI: 10.1158/1078-0432.CCR-07-0902  0.01
2003 Williams JM, Scherzer CB. Tracking the Training and Careers of Graduates of Advanced Degree Programs in Sport Psychology, 1994 to 1999 Journal of Applied Sport Psychology. 15: 335-353.  0.01
2001 Scherzer CB, Brewer BW, Cornelius AE, Van Raalte JL, Petitpas AJ, Sklar JH, Pohlman MH, Krushell RJ, Ditmar TD. Psychological skills and adherence to rehabilitation after reconstruction of the anterior cruciate ligament Journal of Sport Rehabilitation. 10: 165-172.  0.01
2000 Van Raalte JL, Brown TD, Brewer BW, Avondoglio JB, Hartmann WM, Scherzer CB. An on-line survey of graduate course offerings satisfying AAASP certification criteria Sport Psychologist. 14: 98-104.  0.01
1982 Scherzer CE, Goldstein DM. Children's first reading lesson: Variables influencing within-lesson emotional behavior and postlesson achievement Journal of Educational Psychology. 74: 382-392. DOI: 10.1037/0022-0663.74.3.382  0.01
1966 Scherzer CJ. The devotional writings of Russell L. Dicks Pastoral Psychology. 17: 29-34. DOI: 10.1007/BF01762213  0.01
1962 Scherzer CJ. The pastor faces his inner tensions Pastoral Psychology. 13: 19-23. DOI: 10.1007/BF01763684  0.01
1961 Kennedy M, Scherzer CJ, Yoder HW, Millet JAP. Why is christmas depressing to some people? Pastoral Psychology. 12: 53-57. DOI: 10.1007/BF01763391  0.01
1958 Yoder HW, Scherzer CJ, Johnson PE. When is a problem serious enough for pastoral counseling? Pastoral Psychology. 9: 51-53. DOI: 10.1007/BF01744235  0.01
1957 Scherzer CJ. Ego injury in illness Pastoral Psychology. 8: 31-34. DOI: 10.1007/BF01744317  0.01
1952 Scherzer CJ. The protestant confessional - The protestant church does not practice formal confession, but it recognizes the value of confession through pastoral counseling Pastoral Psychology. 3: 42-45. DOI: 10.1007/BF01838241  0.01
1951 Scherzer CJ. The Emmanuel movement - A pioneering attempt to treat personality Pastoral Psychology. 2: 27-33. DOI: 10.1007/BF01788709  0.01
2020 Ihle J, Artaud F, Bekadar S, Mangone G, Sambin S, Mariani LL, Bertrand H, Rascol O, Durif F, Derkinderen P, Scherzer C, Elbaz A, Corvol JC, Corvol JC, et al. Parkinson's disease polygenic risk score is not associated with impulse control disorders: A longitudinal study. Parkinsonism & Related Disorders. 75: 30-33. PMID 32450545 DOI: 10.1016/J.Parkreldis.2020.03.017  0
2015 Chhatwal JP, Schultz AP, Marshall GA, Boot B, Gomez-Isla T, Dumurgier J, LaPoint M, Scherzer C, Roe AD, Hyman BT, Sperling RA, Johnson KA. O4-01-04: Entorhinal, parahippocampal, and inferior temporal F18-T807 SUVR correlates with CSF total tau and tau T181P in cognitively normal elderly Alzheimer's & Dementia. 11: P267-P267. DOI: 10.1016/J.Jalz.2015.07.348  0
2009 Mollenhauer B, Birgit O, Ng J, El-Agnaf O, Scherzer C, Trenkwalde C. Quantification of CSF and blood alpha-synuclein as a diagnostic marker for synucleinopathies Alzheimers & Dementia. 5: 148. DOI: 10.1016/J.Jalz.2009.05.508  0
2004 Gilbert JR, Xu P, Li Y, Qin X, Schmechel D, Hulette C, McLaurin A, Scherzer C, Gullans SR, Haines JL, Pericak-Vance MA. P4-103 APOE allele specific gene expression in Alzheimer's and control hippocampus Neurobiology of Aging. 25. DOI: 10.1016/S0197-4580(04)81661-0  0
Hide low-probability matches.